Nathalie A. Kolandjian

Nathalie Kolandjian practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Nathalie Kolandjian's NPI, 1457747735, was assigned on April 13, 2015. Nathalie Kolandjian graduated from Joe R. & Teresa Lozano Long School of Medicine in 2015. Nathalie Kolandjian's California license number on file is A153625.

Nathalie Kolandjian's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Nathalie Kolandjian's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Nathalie Kolandjian practices. Vendor and product names are available with a free account.

Internal medicine is Nathalie Kolandjian's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Nathalie Kolandjian is board certified in internal medicine by the American Board of Internal Medicine. Nathalie Kolandjian has a license on file in California.

Dmand AI lists acute respiratory failure, cellulitis, congestive heart failure, electrolyte disorders, gastrointestinal inflammation, head wound, kidney failure and lung disease: COPD, asthma or bronchitis among the conditions Nathalie Kolandjian treats.

CMS data shows 432 Medicare services from Nathalie Kolandjian across 4 procedure codes in 2024, for 91 Medicare patients. Medicare paid $30,043 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Nathalie Kolandjian in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 59% are also on Medicaid. Their average risk score is 3.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nathalie Kolandjian's median patient age at 58, with 47% women.

In 2024, Nathalie Kolandjian wrote 113 Medicare Part D claims for 44 patients. 88% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $6,915 in total drug cost. In 2019, CMS named 34 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Nathalie Kolandjian for performance year 2024, reported as part of a group. Nathalie Kolandjian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Nathalie Kolandjian. The most frequent topics are Melanoma and Uveal Neoplasms. Nathalie Kolandjian's most frequent co-authors are Nicholas E. Papadopoulos, MD and Agop Y. Bedikian, MD.

CMS Open Payments shows 1 general payment to Nathalie Kolandjian from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $124.

Nathalie Kolandjian graduated from Joe R. & Teresa Lozano Long School of Medicine in 2015.

Nathalie Kolandjian is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.